PAVmed (PAVM) Gross Profit (2021 - 2026)
PAVmed (PAVM) posted quarterly Gross Profit of -$4000.0 for Q4 2025, up 89.47% year-over-year from -$2111.1 in Q4 2024, and up 92.0% quarter-over-quarter from -$50000.0 in Q3 2025.
PAVmed (PAVM) Gross Profit (2021 - 2026) Analysis & Trends
PAVmed's Gross Profit history runs 5 years deep, the most recent figure standing at -$4000.0 for Q4 2025.
- In Q4 2025, Gross Profit rose 89.47% year-over-year to -$4000.0; the TTM figure through Dec 2025 stood at -$117000.0 (up 94.21% YoY), while the FY2025 annual figure was -$118000.0, up 93.6% from the prior year.
- Gross Profit for Q4 2025 stood at -$4000.0, up from -$50000.0 in the prior quarter.
- The five-year high for Gross Profit was $56000.0 in Q3 2021, with the low at -$1.5 million in Q3 2022.
- The 5-year median for Gross Profit is -$371000.0 (2022), against an average of -$554125.0.
- The sharpest annual moves came in 2022 and 2025: Gross Profit tumbled 2867.86% in 2022, then surged 96.19% in 2025.
- PAVmed's Gross Profit stood at -$141000.0 in 2021, then slumped by 968.09% to -$1.5 million in 2022, then jumped by 62.68% to -$562000.0 in 2023, then surged by 93.24% to -$38000.0 in 2024, then soared by 89.47% to -$4000.0 in 2025.
- Business Quant data shows PAVM's Gross Profit at -$4000.0 in Q4 2025, -$50000.0 in Q3 2025, and -$35000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | PAVmed | 32.44 Mn | 28.66 Mn | -89,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -89,000.00 |
| Jun 30, 2026 | -89,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Sep 30, 2025 | -50,000.00 |
| Sep 30, 2025 | -50,000.00 |
| Jun 30, 2025 | -35,000.00 |
| Jun 30, 2025 | -35,000.00 |
| Mar 31, 2025 | -28,000.00 |
| Mar 31, 2025 | -28,000.00 |
| Dec 31, 2024 | -38,000.00 |
| Dec 31, 2024 | -38,000.00 |
| Jun 30, 2024 | -687,000.00 |
| Jun 30, 2024 | -687,000.00 |
| Mar 31, 2024 | -734,000.00 |
| Mar 31, 2024 | -734,000.00 |
| Dec 31, 2023 | -562,000.00 |
| Dec 31, 2023 | -562,000.00 |
| Sep 30, 2023 | -988,000.00 |
| Sep 30, 2023 | -988,000.00 |